Enliven Therapeutics director Mika Derynck sells $9.56m shares
3 sources
·21h ago
← All stories
Enliven Therapeutics
Pharmaceutical Preparations · US
- HQ
- BURLINGAME, CA
- Industry
- Pharmaceutical Preparations
- Country
- US
In the news · 2
Guggenheim lowers Enliven Therapeutics stock price target to $78
1 source
·1d ago
More in Healthcare